1. Home
  2. CDXS vs DC Comparison

CDXS vs DC Comparison

Compare CDXS & DC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDXS
  • DC
  • Stock Information
  • Founded
  • CDXS 2002
  • DC 2017
  • Country
  • CDXS United States
  • DC United States
  • Employees
  • CDXS N/A
  • DC N/A
  • Industry
  • CDXS Major Chemicals
  • DC Precious Metals
  • Sector
  • CDXS Industrials
  • DC Basic Materials
  • Exchange
  • CDXS Nasdaq
  • DC Nasdaq
  • Market Cap
  • CDXS 230.3M
  • DC 209.6M
  • IPO Year
  • CDXS 2010
  • DC N/A
  • Fundamental
  • Price
  • CDXS $2.11
  • DC $2.82
  • Analyst Decision
  • CDXS Buy
  • DC Buy
  • Analyst Count
  • CDXS 2
  • DC 1
  • Target Price
  • CDXS $11.00
  • DC $7.50
  • AVG Volume (30 Days)
  • CDXS 1.1M
  • DC 738.0K
  • Earning Date
  • CDXS 05-01-2025
  • DC 05-09-2025
  • Dividend Yield
  • CDXS N/A
  • DC N/A
  • EPS Growth
  • CDXS N/A
  • DC N/A
  • EPS
  • CDXS N/A
  • DC N/A
  • Revenue
  • CDXS $59,345,000.00
  • DC N/A
  • Revenue This Year
  • CDXS $12.62
  • DC N/A
  • Revenue Next Year
  • CDXS $22.11
  • DC N/A
  • P/E Ratio
  • CDXS N/A
  • DC N/A
  • Revenue Growth
  • CDXS N/A
  • DC N/A
  • 52 Week Low
  • CDXS $1.90
  • DC $1.84
  • 52 Week High
  • CDXS $6.08
  • DC $3.50
  • Technical
  • Relative Strength Index (RSI)
  • CDXS 35.96
  • DC 52.03
  • Support Level
  • CDXS $1.91
  • DC $2.53
  • Resistance Level
  • CDXS $2.47
  • DC $3.00
  • Average True Range (ATR)
  • CDXS 0.21
  • DC 0.12
  • MACD
  • CDXS 0.02
  • DC 0.03
  • Stochastic Oscillator
  • CDXS 23.86
  • DC 69.95

About CDXS Codexis Inc.

Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.

About DC Dakota Gold Corp.

Dakota Gold Corp is a gold exploration and development company with a specific focus on revitalizing the Homestake District in Lead, South Dakota. Dakota Gold has high-caliber gold mineral properties covering over 48 thousand acres surrounding the historic Homestake Mine.

Share on Social Networks: